A GENETIC variant, the BIM deletion polymorphism (BDP), has been identified by researchers to significantly enhance leukemia ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

Jack Moore, the owner of The Book Review in Rochester’s Hillcrest Shopping Center, delivered the news on social media on ...

Gil Blum, an analyst from Needham, maintained the Buy rating on Autolus Therapeutics (AUTL – Research Report). The associated price ...

Hematologic malignancies, including leukemia, lymphoma, and myeloma, present considerable clinical challenges, driven in part by their unique tumor microenvironments and the ability of cancer cells to ...

The Great Impersonator” unfortunately relies a bit too much upon the rawness of its themes alone, letting its technical ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Syndax (SNDX) announced that multiple abstracts evaluating revumenib, an oral small molecule menin inhibitor, have been accepted for oral ...

Although polycythemia vera management remains focused on reducing the risk of thrombotic events, there is growing recognition ...